Zobrazeno 1 - 10
of 34
pro vyhledávání: '"R R, Bahnson"'
Autor:
R R, Bahnson, G E, Hanks, R P, Huben, P, Kantoff, J M, Kozlowski, M, Kuettel, P H, Lange, C, Logothetis, J M, Pow-Sang, M, Roach, H, Sandler, P T, Scardino, R J, Taylor, D A, Urban, P C, Walsh, T G, Wilson
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
Systemic therapies for prostate cancer are likely to improve, and as they do, they will have enormous impact on the treatment of high-risk and locally advanced cancers. Further technical improvements in radiotherapy and alternative local modalities,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::12beaa5e8ff44f931a4d0af7ef2b3653
https://pubmed.ncbi.nlm.nih.gov/11195405
https://pubmed.ncbi.nlm.nih.gov/11195405
Publikováno v:
Archives of pathologylaboratory medicine. 124(8)
Carcinosarcomas of urinary bladder are rare malignant neoplasms. Seventy-eight cases have been previously described. The histologic composition of these tumors is variable, but diagnosis requires the presence of both epithelial and mesenchymal malign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5d03d404f1ed301ceaab2fcd162d9a1
https://pubmed.ncbi.nlm.nih.gov/10923079
https://pubmed.ncbi.nlm.nih.gov/10923079
Publikováno v:
The Journal of urology. 161(4)
For the treatment of clinically localized prostate cancer radical retropubic prostatectomy with its attendant hospital stay should be associated with higher charges than transperineal prostate brachytherapy. We report a comparative case series to det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10a0bfbd7d7387ba258b91eb6e328f01
https://pubmed.ncbi.nlm.nih.gov/10081872
https://pubmed.ncbi.nlm.nih.gov/10081872
Autor:
R E, Greenberg, R R, Bahnson, D, Wood, S J, Childs, C, Bellingham, M, Edson, M H, Bamberger, G D, Steinberg, M, Israel, T, Sweatman, B, Giantonio, P J, O'Dwyer
Publikováno v:
Urology. 49(3)
This study was designed to assess the pharmacokinetics, safety, and antitumor activity of intravesically administered AD 32, a novel anthracycline, in patients with transitional cell carcinoma (TCC) of the bladder.Six weekly doses of AD 32 (200 to 90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44ea0563604f5f2b372ad5e2d123afe4
https://pubmed.ncbi.nlm.nih.gov/9123721
https://pubmed.ncbi.nlm.nih.gov/9123721
Autor:
B R, Konety, R R, Bahnson
Publikováno v:
Seminars in urologic oncology. 14(3)
The management of stage T1b (A2) and T1c adenocarcinoma of the prostate is somewhat controversial. With the widespread use of serum prostate-specific antigen (PSA) determinations, an increasing number of these cancers are likely to be diagnosed. Henc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02ae7de0172fcc6054eeb9483c59bf61
https://pubmed.ncbi.nlm.nih.gov/8865482
https://pubmed.ncbi.nlm.nih.gov/8865482
Publikováno v:
Cancer research. 56(7)
The early diagnosis of bladder cancer is central to the effective treatment of the disease. Presently, there are no methods available to easily and specifically identify the presence of bladder cancer cells. The prevailing method for the detection of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8156c1292b786a911977ad81abc3269f
https://pubmed.ncbi.nlm.nih.gov/8603421
https://pubmed.ncbi.nlm.nih.gov/8603421
Publikováno v:
The Journal of urology. 154(3)
More than 900 patients who underwent hepatic resections were reviewed to identify those whose liver resections were due to involvement by renal cell carcinoma.Three patients with direct hepatic extension of the renal cell cancer underwent radical nep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3c04cbd503c1dce28e8dac57eefbe546
https://pubmed.ncbi.nlm.nih.gov/7637104
https://pubmed.ncbi.nlm.nih.gov/7637104
Publikováno v:
The Journal of urology. 154(1)
We tested and proved the safety of recombinant human tumor necrosis factor given intravesically weekly for 11 weeks (dwell time 2 hours) for the treatment of superficial bladder cancer in 8 men and 1 woman 46 to 87 years old (mean age 69 years). Coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::60005b206d0ad391ed547a7e69babf72
https://pubmed.ncbi.nlm.nih.gov/7776458
https://pubmed.ncbi.nlm.nih.gov/7776458
Publikováno v:
Surgical oncology clinics of North America. 4(2)
The failure of radical cystectomy to cure the majority of patients with muscle invasive transitional cell carcinoma of the bladder has prompted clinical trials evaluating adjuvant chemotherapy. No properly conducted prospective trials are available t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a4b385d54f3fb4372b960581554b0635
https://pubmed.ncbi.nlm.nih.gov/7796287
https://pubmed.ncbi.nlm.nih.gov/7796287
Publikováno v:
Anticancer research. 14(3A)
1,25-Dihydroxyvitamin D [1,25(OH)2D3, calcitriol] can inhibit the proliferation of some human prostate cancer cells but its clinical use is limited by hypercalcemia. We therefore explored the bioactivity of less calcemic vitamin D analogs. We studied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7e31eef0eea4154941d4176cf551f983
https://pubmed.ncbi.nlm.nih.gov/8074453
https://pubmed.ncbi.nlm.nih.gov/8074453